Drugmakers are growing frustrated with the National Health Service after a clawback tax unexpectedly soared, with pharmaceutical companies warning that investment in the UK may be at risk.
Ana Botin, executive chair of Spanish bank Santander has denied reports that the company is considering leaving the British ...